Meng Xu
- Cancer Research top 1%
- MicroRNA in disease regulation 23
- Cancer-related molecular mechanisms research 16
- Molecular Biology top 5%
- Circular RNAs in diseases 14
- RNA modifications and cancer 10
- Muscle Physiology and Disorders 8
- RNA Research and Splicing 7
- Metabolism, Diabetes, and Cancer 5
- Fibroblast Growth Factor Research 5
- Immunology top 10%
- Oncology top 10%
- Genetics top 10%
- Journals
- SHILAP Revista de lepidopterología (1 paper)The EMBO Journal (1 paper)Molecular Cell (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Meng Xu
101 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 1.2k
- Molecular Biology 2.1k
- Immunology 329
- Oncology 408
- Genetics 157
Countries citing papers authored by Meng Xu
This map shows the geographic impact of Meng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Xu more than expected).
Fields of papers citing papers by Meng Xu
This network shows the impact of papers produced by Meng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Xu. The network helps show where Meng Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meng Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 31 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 7 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 87 | |
| 9 | 2021 | 42 | |
| 10 | 2021 | 75 | |
| 11 | 2019 | 17 | |
| 12 | 2019 | 26 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 2 | |
| 15 | 2019 | 21 | |
| 16 | 2015 | 23 | |
| 17 | 2014 | 51 | |
| 18 | 2014 | 50 | |
| 19 | 2013 | 19 | |
| 20 | [Effect of supplement energy and nourish lung herbs on drug-resistance lung cancer with mechanisms of mitochondrial and caspase signal]. | 2008 | 2 |
About Meng Xu
Meng Xu is a scholar working on Cancer Research, Aging and Molecular Biology, having authored 104 papers that have together received 3.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (16 papers), Circular RNAs in diseases (14 papers), RNA modifications and cancer (10 papers), Muscle Physiology and Disorders (8 papers), RNA Research and Splicing (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Fibroblast Growth Factor Research (5 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (2.1k citations) and Immunology (329 citations). Meng Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Cheng‐Xiong Xu, Wenzhi Bi, Hua Jin, Zhiqing Huang, Daiwen Chen, Bing Yu, Xiaoling Chen, Zhiyin Song, Heng Fan and Laurent Désaubry. Their work appears in journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.